ArticleBriefings in bioinformatics2026
iDLDDG: predicting protein stability changes from missense mutations in DNA-binding proteins using integrated deep learning features.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To understand disease mechanisms and advance therapies, accurately predicting how missense mutations alter protein-DNA binding affinity is critical. Many existing models neglect the unique characteristics of missense mutations in both double-stranded DNA-binding proteins (DSBs) and single-stranded DNA-binding proteins (SSBs). To address this issue, we constructed a comprehensive dataset from diverse sources. By leveraging sequence-based embeddings from pretrained protein language models including ESM2, ProtTrans, and ESM1v, we developed iDLDDG, a deep learning framework that integrates multi-scale structural and evolutionary information via a multi-channel architecture. To balance residue-wise information density against entropy, our entropy-based algorithm determined 181 residues as optimal for modeling biophysical constraints. This approach enhances predictive accuracy and computational efficiency, thereby supporting large-scale assessments of mutation effects in DNA-binding proteins. iDLDDG achieves state-of-the-art performance, with a 10-fold cross-validation PCC of 0.755 on MPD276 and 0.632 on independent test sets encompassing both DSBs and SSBs, significantly surpassing existing methods. By establishing the first computational framework that rigorously differentiates DSB and SSB mutation mechanisms, our work provides a foundation for high-accuracy prediction of pathological mutations in DNA-binding proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.